Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine for Blood Pressure Control in Elderly Hypertensive Patients Undergoing Cataract Surgery
NCT07080229Phase 3Recruiting
- Sponsor
- Suez Canal University
- Start
- Jul 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in hypertension (HTN), sponsored by Suez Canal University. Started Jul 2025; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT07080229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07080229.